Cerenome to Hold CNSide® Business Update Call on September 30, 2026
Plus Therapeutics Inc CNSY
$1.99
▲ +6.42%
(+$0.12)
⬆️ Above Yest. High
Open
$1.92
Prev Close
$1.87
Day Range
$1.92 – $2.08
52W Range
$1.86 – $4.16
Market Cap
$15.10M
Beta
2.00
EPS (TTM)
$-4.42
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-08-09 |
| Shares Out. | 6,880,000 |
| Website | plustherapeutics.com/ ↗ |
| Phone | 13026365440 |
| Employees | 28 |
About Plus Therapeutics Inc
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Plus Therapeutics Inc is a publicly traded company under the ticker symbol CNSY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-09-01)